An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 1, 2002-12 ,pp. : 44-54

Karger

Access to resources Recommend Favorite

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 399-407

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 2, 2011-02 ,pp. : 158-164

Karger

Access to resources Recommend Favorite

A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 1, 2003-05 ,pp. : 15-24

Karger

Access to resources Recommend Favorite